Buffers Benefit from Single-Use Systems
Single-use systems offer a solution to the challenges inherent in buffer preparation, which can be the cause of bottlenecking in bioprocessing.
Because the manufacturing of biotherapeutics requires large volumes of process liquids, buffer preparation is an important aspect of large-scale biomanufacturing. To address the challenges of buffer preparation and ease bottlenecking, MilliporeSigma developed the BioContinuum Buffer Delivery Platform, a new component to its BioContinuum Platform. BioPharm Internationalspoke with Andrew Bulpin, head of process solutions at MilliporeSigma, about what the company’s buffer delivery platform entails, such as single-use components, and the benefits it offers to biomanufacturers.
Read this article in BioPharm International's Single-Use Systems 2019 eBook.
Article Details
BioPharm International
eBook: Single-Use Systems 2019
Vol. 32
June 2019
Pages: 14–17
Citation
When referring to this article, please cite it as F. Mirasol, "Buffers Benefit from Single-Use Systems," BioPharm International Single-Use SystemseBook (June 2019).
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.
